TYPE 2 DIABETES MELLITUS PATHOGENESIS AND ITS COMPLICATIONS
Article Sidebar
Main Article Content
Аннотация:
Diabetes mellitus is characterized by impaired insulin secretion and varying degrees of insulin resistance, causing hyperglycemia. Early symptoms are associated with hyperglycemia and include polydipsia, polyphagia, polyuria, and visual field constriction. Late complications include angiopathy, peripheral neuropathy, nephropathy, and predisposition to infectious diseases. Diagnosis is based on the measurement of plasma glucose levels. Treatment includes diet, exercise, and glucose-lowering agents, including insulin, oral antidiabetic drugs, and non-insulin injectables. Complications can be delayed or prevented by proper glycemic control; Cardiac disease remains the leading cause of death in diabetes mellitus.
Article Details
Как цитировать:
Библиографические ссылки:
Fomin I.V. Chronic heart failure in the Russian Federation: what today we know and what we should do // Russian Journal of Cardiology. 2016. No. 8. pp. 7-13.
M.V. Shestakova, O.K. Vikulova, A.V. Zheleznyakova, M.A. Isakov, I.I. Dedov. Epidemiology of diabetes mellitus in the Russian Federation: what has changed in recent years decade? // Therapeutic archive. 2019. No. 10. From 4-13.
Kengne A.P., Turnbull F., MacMahon S. The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock. Prog CardiovascDis. 2010. vol. 53. R 45-51.
Mardanov B.U., Korneeva M.N., Akhmedova E.B. heart failure and diabetes diabetes: certain issues of etiopathogenesis, prognosis and treatment // Rational pharmacotherapy in cardiology. 2016. No. 12(6). From 743-748.
Oikonomou E., Mourouzis K., Fountoulakis P., Papamikroulis G.A., Siasos G., Antonopoulos A., Vogiatzi G., Tsalamadris S., Vavuranakis M., Tousoulis D. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors left ventricular performance. Heart Fail Rev. 2018.vol. 23 no. 3. R. 389-408.
Birkenfeld, A. L., Jordan, J., Dworak, M., Merkel T., Burn stock, G. Myocardial metabolism in heart failure: Purinergic signaling and other metabolic concepts. Pharmacology and Therapeutics. Pharmacol Ther. 2019.vol. 194. R. 132-144.
Selvin E., Lazo M., Chen Y., et al. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. circulation. 2014.vol. 130. R. 1374-82.
Riehle C., Abel E.D. Insulin Signaling and Heart Failure. Circ Res. 2016.vol. 118. R. 1151-69.